Balance Sheet
Cash Flow Statement
AmortizationAmortizationAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet Income
Growth Metrics
Income Statement
Others
Ratios

Avricore Health (AVCRF) Asset Writedowns and Impairment (2017 - 2020)

Avricore Health has reported Asset Writedowns and Impairment over the past 5 years, most recently at $137721.6 for Q4 2020.

  • Quarterly Asset Writedowns and Impairment rose 265.37% to $137721.6 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $52307.2 through Dec 2020, up 118.31% year-over-year, with the annual reading at $302714.4 for FY2025, 153.67% up from the prior year.
  • Asset Writedowns and Impairment was $137721.6 for Q4 2020 at Avricore Health, up from $321.93 in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $256993.0 in Q1 2017 and troughed at -$895244.4 in Q4 2017.
  • The 4-year median for Asset Writedowns and Impairment is -$46090.9 (2017), against an average of -$74843.8.
  • Year-over-year, Asset Writedowns and Impairment tumbled 252.59% in 2018 and then surged 265.37% in 2020.
  • A 4-year view of Asset Writedowns and Impairment shows it stood at -$895244.4 in 2017, then soared by 86.54% to -$120520.6 in 2018, then surged by 30.9% to -$83280.1 in 2019, then surged by 265.37% to $137721.6 in 2020.
  • Per Business Quant, the three most recent readings for AVCRF's Asset Writedowns and Impairment are $137721.6 (Q4 2020), $321.93 (Q3 2020), and -$83280.1 (Q4 2019).